Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation

suPAR: The Molecular Crystal Ball

(2013) Maria Thunø et al.   DISEASE MARKERS

Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection

(2013) Tuula K. Outinen et al.   PLoS One

Soluble Urokinase Plasminogen Activator Receptor is Associated With Inflammation in the Vulnerable Human Atherosclerotic Plaque

(2012) Andreas Edsfeldt et al.   STROKE

Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events

(2011) T. Sehestedt et al.   ATHEROSCLEROSIS

Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study

(2011) M. Persson et al.   ATHEROSCLEROSIS

Increased Plasma Soluble uPAR Level Is a Risk Marker of Respiratory Cancer in Initially Cancer-Free Individuals

(2011) A. Langkilde et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study

(2011) Samuel Adamsson Eryd et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study

(2011) Yan Borné et al.   EUROPEAN JOURNAL OF HEART FAILURE

Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study

(2011) R. Huttunen et al.   JOURNAL OF INTERNAL MEDICINE

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

(2011) Changli Wei et al.   NATURE MEDICINE

Country of birth and risk of hospitalization due to heart failure: a Swedish population-based cohort study

(2010) Yan Borné et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population

(2010) J. Eugen-Olsen et al.   JOURNAL OF INTERNAL MEDICINE

Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial Fibrillation

(2010) J. Gustav Smith et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Relation of Multiple Inflammatory Biomarkers to Incident Atrial Fibrillation

(2009) Renate B. Schnabel et al.   AMERICAN JOURNAL OF CARDIOLOGY

N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation

(2009) Kristen K. Patton et al.   CIRCULATION

Leukocyte Count and Incidence of Hospitalizations Due to Heart Failure

(2009) Gunnar Engström et al.   Circulation-Heart Failure

Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity

(2009) J. Gustav Smith et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Release of the Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) by Activated Neutrophils in Rheumatoid Arthritis

(2009) Boris K. Pliyev et al.   INFLAMMATION

Novel and Conventional Biomarkers for Prediction of Incident Cardiovascular Events in the Community

(2009) Olle Melander   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

(2009) Renate B Schnabel et al.   LANCET

Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: A population-based cohort study

(2008) Gunnar Engström et al.   ATHEROSCLEROSIS

Accuracy of a heart failure diagnosis in administrative registers

(2008) Thomas Kümler et al.   EUROPEAN JOURNAL OF HEART FAILURE